Prostaglandin E2 Inhibition and Aqueous Concentration of Ketorolac 0.4% (Acular LS) and Nepafenac 0.1% (Nevanac) in Patients Undergoing Phacoemulsification
Frank A. Bucci Jr, L. David Waterbury, Loretta M. AmicoVolume:
144
Year:
2007
Language:
english
Pages:
148
DOI:
10.1016/j.ajo.2007.02.034
File:
PDF, 157 KB
english, 2007